Glutaminase inhibitors are a class of drugs designed to block the activity of the enzyme glutaminase. Glutaminase converts glutamine into glutamate, a crucial step in the metabolic pathways that fuel rapidly dividing cancer cells. By inhibiting this enzyme, these drugs aim to disrupt the metabolic processes that cancer cells rely on for growth and survival.